Scientists reveal pill that helps shed 20% of body weight

Abstract A new kind of weight-loss medicine is making waves in medical research — Orforglipron , the first small-molecule, nonpeptide oral GLP-1 receptor agonist. Unlike existing GLP-1 drugs that require injections, this one comes as a pill. In a major phase 3 trial, it showed remarkable success in helping people with obesity lose weight safely and consistently. Orforglipron represents a new era in obesity treatment — an oral GLP-1 receptor agonist that delivers powerful weight-loss results without injections. In clinical trials, it helped participants lose up to 11% of their body weight while improving blood pressure and metabolic health. Photo by Diana Polekhina on Unsplash Background Obesity isn’t just about appearance — it’s a complex health issue that affects the heart, metabolism, and even mental well-being. Diet and exercise remain the cornerstones of treatment, but for many, they’re not enough. Over the last few years, injectable GLP-1 drugs like semaglutide have helped mi...